SERPINA1 and alpha 1-antitrypsin deficiency: Intravenous alpha-1 antitrypsin (IV-AAT) shows a significant and demonstrable survival advantage in people with severe AAT deficiency (AATD), but there is a disconnect between survival and spirometric lung function in AATD.